Advertisement

Ads Placeholder
Loading...

Natera, Inc.

NTRANASDAQ
Healthcare
Medical - Diagnostics & Research
$207.98
$4.77(2.35%)
U.S. Market opens in 19h 41m

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap29.5B
P/E Ratio-136.60
EPS (TTM)$-1.52
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$218.04
3 Months$221.91
1 Year Target$280.34

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -136.60 and a market capitalization of 29.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.35%
5-Day Change
6.28%
1-Month Change
0.45%
3-Month Change
-9.12%
6-Month Change
24.28%
Year-to-Date (YTD) Change
-9.12%
1-Year Change
49.94%
3-Year Change
283.23%
5-Year Change
96.23%
All-Time (Max) Change
1055.44%

Contact Information

650 249 9090
13011 McCallen Pass Building A, Austin, CA, 78753

Company Facts

44,240 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions